What Experts Say About Us

Yutao Liu, MD, PhD
Congratulations to the Annals of Eye Science and the editorial team with the significant and latest impact factor for the 2025! This well-deserved recognition clearly demonstrates the significant impact of AES in the ophthalmology clinical and basic research area. The international impact of AES reflects the openness of the journal and the strategic goals of the editorial leadership and the team. I am confident that AES will make significant progress and achievement in continuous publishing impactful ophthalmology and vision science research papers in the future.
Yutao Liu, MD, PhD
Editorial Board Member of AES
Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA

 

Written on July 23, 2026

Sanjoy Bhattacharya, MSc., MTech, PhD
AES is a great avenue for publishing scientific work. I greatly enjoyed publishing at AES some of our high quality review/perspectives that also included some new pertinent experimental findings. Journal offers speedy but quality reviews. We have experienced good-quality, constructive reviews that improved our rigor and presentation.
Sanjoy Bhattacharya, MSc., MTech, PhD
Editorial Board Member of AES
Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA

 

Written on August 7, 2026

Yousif Subhi, MD, PhD
It is a pleasure to celebrate this important milestone for Annals of Eye Science. Achieving an Impact Factor is not only a recognition of past efforts but also an opportunity to build an even stronger international journal.

The future of ophthalmology will increasingly depend on robust clinical evidence, large-scale data, digital health, and artificial intelligence. Journals have an essential role in ensuring that these innovations are evaluated with scientific rigor and translated into meaningful improvements in patient care. I am confident that AES will continue to provide a platform for high-quality research, thoughtful discussion, and international collaboration across all areas of vision science.

Congratulations to everyone who has contributed to this achievement. I look forward to seeing AES continue its upward trajectory in the years to come.
Yousif Subhi, MD, PhD
Editorial Board Member of AES
Department of Ophthalmology, Rigshospitalet-Glostrup, Glostrup, Denmark; Department of Ophthalmology, Zealand University Hospital, Roskilde, Denmark

 

Written on July 22, 2026

Kenneth G-J Ooi
It is a great privilege to be associated with the Annals of Eye Science team as its continues growth on the advent of its latest impact factor and CiteScore metrics. Its current overall ranking rise to 79 out of 147 journals in the Ophthalmology category since inception is testimony to the global reach of the editorial group. Great foresight has been shown by the AES team in assembling the machinery required to facilitate the ease with which authors and reviewers are able to access, literally, world class peer validation. It is also with continuing thanks to be of service as part of the editorial board as AES continues to crystallise.
Kenneth G-J Ooi
Editorial Board Member of AES
Save Sight Institute, University of Sydney, Sydney, Australia

 

Written on September 5, 2026

Andrew G. Lee, MD
Congratulations to Annals of Eye Science on reaching an important milestone. This achievement is a testament to your commitment to scientific inquiry, the peer-review process, and high-quality research. I am sure that all of us as authors, reviewers, and editorial board members share in the joy and celebration of the journal’s success.

In the Japanese spirit of “Kaizen” (change for better), true success is a journey of continuous, incremental improvement. Reaching a higher impact factor is not a final destination, but a strong start and is a vital stepping-stone for the journal to further elevate its standing and standards, expand its global reach, and publish even more transformative ophthalmic research.

We celebrate this benchmark and achievement with you today and I look forward to continued kaizen for the future.
Andrew G. Lee, MD
Editorial Board Member of AES
Department of Ophthalmology, Houston Methodist Hospital in Houston, Texas, USA

 

Written on August 7, 2026

Dmitrii S. Maltsev, MD, PhD, DSc
We congratulate Annals of Eye Science on obtaining its latest impact factor of 1.0 for the 2025 citation year! Over the past three years (from 2022 to 2025), Annals of Eye Science has demonstrated remarkable growth, with its SJR indicator increasing by 314%. During this period, the journal rose from the fourth quartile to a stable second quartile. This impressive trajectory places it among the fastestdeveloping ophthalmology journals. Indexation in Scopus and PubMed Central ensures strong visibility and citation potential. If the current trend continues, the journal has every chance of entering the first quartile within the next one to two years. For authors who prioritize open access and growthoriented publications, Annals of Eye Science represents an attractive platform, particularly in the fields of retinal and surgical ophthalmology, where we have seen excellent review articles devoted to the most compelling topics. For a growing number of authors, publishing in Annals of Eye Science opens up opportunities to advance together with the journal. With its remarkable growth, expanding visibility, and highquality content, Annals of Eye Science is well positioned to become one of the leading journals in ophthalmology, and we look forward to its continued success in the coming years.
Dmitrii S. Maltsev, MD, PhD, DSc
Editorial Board Member of AES
Head of medical retina division, Ophthalmology department, Military Medical Academy, St. Petersburg, Russia Clinical Professor, Ophthalmology department, Military Medical Academy, St. Petersburg, Russia

 

Written on August 10, 2026